News
Engineers develop bio-machine nose that can “sniff” and classify odors
Engineers from Brown University in Rhode Island have invented a small, low-cost sensor device which is able to classify odors using input from a mimicked “sniffing” action. It’s called TruffleBot, and it’s here to raise the bar on electronic “noses”. It also works with Raspberry Pi, an inexpensive mini-computer popular with electronics hobbyists, students, and others in the “maker” crowd.
Generally, an electronic nose is a device comprising several chemical sensors whose results are fed through a pattern-recognition system to identify odors. In traditional devices, the chemical responses alone are used for classification. The engineers behind this invention, however, decided to incorporate non-chemical data to account for the mechanics of the smell process used in nature for a better result. Their experiment proved successful with an approximate 95-98% rate of accuracy in identification compared to about 80-90% accuracy with the chemical sensors alone.
According to the inventors’ published paper, the guiding knowledge that made TruffleBot so useful in odor detection was this: Different smells have different impacts on the air around them, and measuring the variations enables more accurate identification. Did you know that beer odor decreases air pressure and increases temperature? The changes are slight, but TruffleBot can sense them.
This is where the “sniffing” comes in. The device uses air pumped through four obstructed pathways before sending it through chemical and non-chemical sensors. Odors impact the air surrounding them, and the movement of the air through obstacles (“sniffing”) enables the odors’ impact to be more accurately measured.
A chart detailing how TruffleBot processes odors. | Credit: Brown University
So, where exactly would one need an electronic nose? Everywhere. Devices with the chemical sensing ability are being used in agriculture, military, and commercial applications to identify all sorts environmental data. Essentially, electronic noses are useful in any industrial application that has odor involved.
Nasal Marketing
Did you know that it’s possible to trademark a smell in the United States? It’s not easy to accomplish given the somewhat difficult requirements to meet, but a few such things exist. The fact that Play-Doh, a product whose smell is probably one of its most distinct features, was granted a trademark for the scent only this year is testament to the difficulty of obtaining such a mark. However, the fact that some companies have found enough incentive to make sure only their company can give your nose a particular chemical experience tells a lot about that sense’s importance from a marketing perspective.
On one hand, utilizing smell in marketing might seem a little manipulative. After all, creating an air freshener that reminds someone of a beloved, deceased relative on purpose might not seem like a particularly ethical way to target their money. On the other hand (or bigger picture), however, the motivation for marketers to use scent as a tool involves a sort of “chicken or the egg” question.
To summarize part of an article in the journal Sensors on the role scent plays in society and commerce, the aroma of products has a direct impact on their appeal to customers and thus, the success of the product. In fact, a change in a product’s formula that impacts its smell can, and often has had, devastating sales results. In other words, it’s not enough for a company to create a good product; it has to be a good smelling product.
Hacking the Human Nose
It’s probably no surprise that the commercial industry has categorized consumer preferences when it comes to smells. As the first sense fully developed after birth, our noses link us to things like memories, emotions, and chemical communication (think pheromones). Is it any wonder, then, why businesses might be interested in the functionality of the organ that is doing the receiving?
Turns out, there’s an enormous amount of science behind “hacking” a nose. Identifying smells is more than just categorizing chemical mixtures as “floral” or “masculine”. The multitude of chemical combinations available generates such a vast amount of data that scientists have implemented computer neural networks to analyze and classify it. Also, the actual mechanics of smelling something impacts the way the smell is received and processed in the brain. Computers and scientific instruments come in handy there as well. To really get to the core of human response to an aroma, lots of non-human tools are needed, and this is essentially where the TruffleBot fits in the greater realm of “olfactory” science.
I think this is a Sumerian variant for “fruity”. | Credit: AstroJane’s bathroom collection.
More Than Just Your Money
Perhaps one of the most innovative uses found for electronic noses is in disease research. One of the limitations of human smell is its overall weakness. A dog’s sense of smell is around 40 times better than a human’s, and a bear’s is a whopping 2,100 times superior to ours. That said, when researchers learned that certain diseases give off certain odors, the human nose wasn’t exactly the first choice to utilize in sensing them.
An electronic nose makes good use of the simple fact that organic matter releases chemicals into the air. For example, when a plant has been impacted by a fungus, the changes brought on in the plant’s structure release what’s called “volatile organic compounds” (VOCs). These VOCs can be detected by the sensors in an electronic nose and then provide information on the type of disease present without destroying the plants being tested.
Humans have some amazing things to gain from electronic noses, too. Using sensors to process odors from VOCs, things like digestive diseases, kidney diseases, and diabetes, among many others, are all receiving scientific attention for non-invasive diagnosis by these types of devices. With improvements brought on by inventions like TruffleBot, especially combined with its low-cost and resulting accessibility, a future involving remote diagnoses for any number of illnesses and diseases seems more possible every day.
Elon Musk
SpaceX wins its first MARS contract but it comes with a catch
NASA awarded SpaceX a $175 million Mars rover contract while the White House proposes cutting the mission.
NASA just signed a $175.7 million contract with SpaceX to launch a Mars rover that the White House is simultaneously trying to defund. The contract, awarded on April 16, 2026, tasks SpaceX’s Falcon Heavy with launching the European Space Agency’s (ESA) Rosalind Franklin rover from Kennedy Space Center in Florida, no earlier than late 2028. It would mark the first time SpaceX has ever sent a payload to Mars.
Under NASA’s Rosalind Franklin Support and Augmentation project, known as ROSA, the agency is providing braking engines for the rover’s descent stage, radioisotope heater units that use decaying plutonium to keep the rover warm on the Martian surface, additional electronics, and a mass spectrometer instrument, as noted by SpaceNews.
Those nuclear heating units are the reason an American rocket was required at all. U.S. export controls on radioisotope technology mean any payload carrying them must launch on a domestic vehicle, which narrowed the field to SpaceX and United Launch Alliance. Falcon Heavy’s pricing made it the practical choice.
SpaceX is quietly becoming the U.S. Military’s only reliable rocket
Falcon Heavy debuted in February 2018 and has 11 launches to its record. The rocket has not flown since October 2024, when it sent NASA’s Europa Clipper toward Jupiter. The three-core design, built from modified Falcon 9 first stages, gives it the lift capacity needed for deep space planetary missions that a single Falcon 9 cannot reach.
The Rosalind Franklin rover has been sitting in storage in Europe for years. It was originally due to launch in 2022 as a joint mission with Russia, but Russia’s invasion of Ukraine ended that partnership, leaving the rover built but stranded without a launch vehicle or landing hardware. NASA stepped back in through a 2024 agreement with ESA to rescue the mission. The rover is designed to drill up to two meters below the Martian surface in search of evidence of past life, a science objective no previous mission has attempted at that depth.
The contradiction at the center of this story is hard to ignore. The White House’s fiscal year 2027 budget proposal included no funding for ROSA and did not mention the mission at all in the detailed congressional justification document released April 3.
Musk has long argued that reaching Mars is not optional. “We don’t want to be one of those single planet species, we want to be a multi-planet species.” Whether this particular mission survives Washington’s budget fight, the Falcon Heavy contract means SpaceX is now formally on record as the rocket that could get humanity’s next Mars science mission off the ground.
The timing of this contract carries extra weight given that SpaceX filed confidentially with the SEC in early April and is targeting an IPO roadshow in the week of June 8. It would be the largest public offering in history.
Tesla (NASDAQ: TSLA) is set to hold its Earnings Call for the first quarter of 2026 on Wednesday, and there are a lot of interesting things that are swirling around in terms of speculation from investors.
With the company’s executives, including CEO Elon Musk, answering a handful of questions that investors submit through the Say platform, fans want to know a lot of things about a lot of things.
These five questions come from Retail Investors, who are normal, everyday shareholders:
- When will we have the Optimus v3 reveal? When will Optimus production start, since we ended the Model S and Model X production earlier than mid-year? What’s the expected Optimus production rate exiting this year? What are the initial targeted skills?
- What milestones are you targeting for unsupervised FSD and Robotaxi expansion beyond Austin this year, and how will that drive recurring revenue?
- How will Hardware 3 cars reach Unsupervised Full Self-Driving?
- When do you expect Unsupervised Full Self-Driving to reach customer cars?
- When will Robotaxi expand past its current limited rollout?
Additionally, these are currently the three questions that are slated to be answered by Institutional Firms, which also answer a handful of questions during the call:
- Now that FSD has been approved in the Netherlands and is expected to launch across Europe this summer, can you discuss your Robotaxi strategy for the region?
- What enabled you to finish the AI5 tapeout early and were there any changes to the original vision? Last week, Elon said AI5 will go into Optimus and the Supercomputer, but one month ago said it would go into the Robotaxi. Has AI5 been dropped from the vehicle roadmap?
- Given the recent NHTSA incident filings, can you update us on the Robotaxi safety data? If safety validation remains the primary bottleneck, why not deploy thousands of vehicles to accelerate the removal of the safety driver?
The questions range through every current Tesla project, including FSD expansion and Optimus. However, many of the answers we will get will likely be repetitive answers we’ve heard in the past.
This is especially pertinent when the questions about when Unsupervised FSD will reach customer cars: we know Musk will say that it will happen this year. Is Tesla capable of that? Maybe. But a more transparent answer that is more revealing of a true timeline would be appreciated.
Hardware 3 owners are anxiously awaiting the arrival of FSD v14 Lite, which was promised to them last year for a release sometime this year.
The Earnings Call is set to take place on Wednesday at market close.
Elon Musk
Elon Musk reveals shocking Tesla Optimus patent detail
What looked promising on paper and in simulations failed to deliver the reliability required for a robot expected to handle delicate tasks like folding laundry, assembling electronics, or assisting in factories and homes.
Elon Musk revealed a shocking detail on the Tesla Optimus patent that was revealed last week. Despite it being made public for the first time, Musk said the company has already moved on from the design, an incredible truth about the development of new technology: things move fast.
Musk dropped a bombshell about the Tesla Optimus humanoid robot hand patent that was released last week. Musk, candidly replying to a post late at night on X, revealed that what is a new technology to many fans and insiders is actually old news to those developing the tech directly.
“We already changed the design,” Musk said. “This one didn’t actually work.”
We already changed the design. This one didn’t actually work.
— Elon Musk (@elonmusk) April 19, 2026
Patents, after all, are often viewed as blueprints for future products. Yet Musk revealed that the rolling contact mechanism—intended to provide smooth, low-friction articulation in the fingers—had already been scrapped after real-world testing exposed its shortcomings.
What looked promising on paper and in simulations failed to deliver the reliability required for a robot expected to handle delicate tasks like folding laundry, assembling electronics, or assisting in factories and homes.
The hand has been one of the biggest challenges for Tesla engineers since Optimus development started years ago. Musk has said that there is not enough recognition for how incredible and useful the human hand is, and designing one for a humanoid robot has been the biggest challenge of all.
Tesla is stumped on how to engineer this Optimus part, but they’re close
This moment underscores the persistent engineering hurdles in achieving reliable humanoid hand dexterity. Human fingers are marvels of evolution: 27 bones, intricate tendons, ligaments, and a network of sensors working in perfect harmony. Replicating that in metal and silicon is extraordinarily difficult.
Rolling contacts promised reduced wear and precise motion, but testing likely revealed issues with durability under repeated stress, grip stability on varied surfaces, or the micro-precision needed for fine motor skills.
These aren’t minor tweaks, but instead they represent fundamental challenges that have plagued robotics teams for decades. Even advanced competitors struggle here—hands remain the Achilles’ heel of most humanoids because the margin for error is razor-thin.
A fraction of a millimeter off, and a robot drops a glass or fails to button a shirt.
What makes Musk’s reply remarkable is how it signals Tesla’s direct communication style on prototype limitations. While many companies guard failures behind glossy marketing and vague timelines, Tesla openly shares setbacks.
Musk was forthcoming about the failure of this recent design. This transparency builds trust with investors, engineers, and fans. It shows Tesla treats Optimus development like true science: rapid iteration, rigorous testing, and zero tolerance for hype that doesn’t match reality.
The disclosure from Musk also highlights Tesla’s blistering pace of development. By the time the patents are published, which is often over a year after the initial filing, the technology has already evolved.
Optimus is far from a static product, and it’s a living project advancing weekly.
In the high-stakes race for general-purpose robots, Tesla’s approach stands out. Admitting a finger-joint design “didn’t actually work” isn’t a weakness—it’s confidence.
True innovation demands confronting failure head-on, and Musk just reminded the world that Optimus is being engineered that way. The next version of those hands is already in testing, and it will be better because Tesla isn’t afraid to say what didn’t work.
SpaceX wins its first MARS contract but it comes with a catch
Tesla Q1 Earnings: What Elon Musk and Co. will answer during the call
